The experience of using micronized estradiol in the preoperative period in patients with postmenopausal genital prolapse

Introduction . The aim is to evaluate the efficacy and safety of the use of micronized estriol produced in the form of a vaginal cream in the preoperative period in patients with pelvic floor muscle failure in postmenopause. Aim. To evaluate the efficacy and safety of the use of micronized estriol in the preoperative period in patients with pelvic organ prolapse (POP) in postmenopause. Results. The effectiveness of therapy with the studied drug made it possible to obtain a rapid clinical effect with a significant improvement in the condition of the mucous membranes and a decrease in the manifestation of IVA in patients already at the end of the first week of use. No side effects or adverse events were detected against the background of Ovestin use. Conclusion. The experience of preoperative preparation using Ovestin (Aspen Bad Oldesloe GmbH, Germany), in the form of a vaginal cream (1 mg/g, 15 g, with a calibrated applicator) in patients with genital prolapse in postmenopausal provides restoration of the structure and elasticity of the vaginal mucosa, which contributes to the uncomplicated course of the postoperative period.